Jolana H.
- Country
- Czechia
- Department
- Clinic
Research Overview
- Comparative Bioavailability Study of UDCA PMCS 500 mg Formulations in Healthy Volunteers Under Fasting Conditions
- Bioavailability Study of Telmisartan, Indapamide, and Amlodipine Interaction in Healthy Volunteers Under Fasting Conditions
- Bioequivalence Study of GP-IMP-001 in Comparison to Reference Product in Healthy Volunteers
Data & Insights
Has run more than one trial at 1 of 2 partner sites.
Specializations
Cardiovascular Research
The investigator focuses on therapeutic interventions for cardiovascular conditions, particularly in the management of hypertension and blood clotting disorders. Their research encompasses studies of various antihypertensive medications and their combinations.
- Antihypertensive therapy combinations
- Blood pressure management
- Anticoagulation treatments
Studies include evaluations of telmisartan, amlodipine, and ramipril-based therapies.
Metabolic Disorders
The investigator conducts research in metabolic health, with particular emphasis on type 2 diabetes management and cholesterol regulation. Their work extends to treatments for various metabolic conditions.
- Diabetes management
- Cholesterol regulation
- Metabolic syndrome treatments
Research includes studies of dapagliflozin and ursodeoxycholic acid applications.
Specialized Therapeutic Areas
The investigator explores treatments for specific medical conditions including myasthenia gravis and influenza. Their research encompasses both chronic condition management and acute illness treatment.
- Neurological disorders
- Antiviral treatments
- Chronic disease management
Studies include evaluations of pyridostigmine bromide and various antiviral medications.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.